Innoviva Statistics
NASDAQ: INVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
18.410.00 (0.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Innoviva by the numbers
Innoviva has a market capitalization of $1.31 billion based on 71.08M shares outstanding. Its trailing P/E ratio is 7.8, and its forward P/E is 8.3. The stock trades 9.9% below its 50-day average and 15.6% below its 200-day average.
Average daily trading volume is 865.66K shares, or about $15.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INVA valuation vs. peer median
| Metric | INVA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.31B | $1.35B | -3% |
| Avg. volume | 865.66K | 581.89K | +49% |
Peer median across 8 companies: NUVB, NBTX, PAHC, AVLN, URGN, QURE, LBRX, RAPP.
Valuation
- Market cap
- $1.31B
- P/E (TTM)
- 7.83
- Forward P/E
- 8.33
- Price / sales (latest FY)
- 3.18
- EPS (TTM)
- $2.35
- Shares outstanding
- 71.08M
Price and trading
- Previous close
- 18.41
- Open
- 18.41
- Day range
- 18.33 – 18.79
- 52-week range
- 18.19 – 25.15
- 52-week change
- -12.17%
- Beta
- —
- Volume
- 1.15M
- Average volume
- 865.66K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.31B
- Pe
- 7.83
- Forward Pe
- 8.33
- Eps
- 2.35
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.15
- Week52 Low
- 18.19
- Avg Volume
- 865.66K
- Shares Outstanding
- 71.08M
- Ma50
- 20.44
- Ma200
- 21.82
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -26.80%
- Pct From52w Low
- 1.21%